MARKET

BCLI

BCLI

Brainstorm Cell Therapeutics I
NASDAQ
0.2204
+0.0155
+7.56%
Opening 13:17 09/29 EDT
OPEN
0.2199
PREV CLOSE
0.2049
HIGH
0.3000
LOW
0.2050
VOLUME
4.13M
TURNOVER
0
52 WEEK HIGH
4.560
52 WEEK LOW
0.1693
MARKET CAP
9.92M
P/E (TTM)
-0.3693
1D
5D
1M
3M
1Y
5Y
Nasdaq Rises Over 100 Points; Accenture Shares Fall After Q4 Results
Benzinga · 1d ago
Health Care Sector Update for 09/28/2023: BNOX, BOLT, BCLI
NASDAQ · 1d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 1d ago
Crude Oil Moves Lower; CarMax Posts Downbeat Earnings
Benzinga · 1d ago
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Benzinga · 1d ago
Dow Rises 80 Points; US Jobless Claims Edge Higher
Benzinga · 1d ago
Maxim Group Downgrades Brainstorm Cell to Hold
Benzinga · 1d ago
More
About BCLI
Brainstorm Cell Therapeutics Inc. is a biotechnology company. The Company is engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis (PMS), Alzheimers disease (AD) and other neurodegenerative diseases. NurOwn, the Company’s cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells (MSCs) to secrete high levels of neurotrophic factors (NTFs), modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. NurOwn has completed its Phase III ALS and Phase II PMS clinical trials. Its wholly owned Israeli subsidiary, BrainStorm Cell Therapeutics Ltd., holds rights to commercialize its NurOwn technology. Its other subsidiaries include Advanced Cell Therapies Ltd. and two others.

Webull offers kinds of Brainstorm Cell Therapeutics Inc stock information, including NASDAQ:BCLI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCLI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BCLI stock methods without spending real money on the virtual paper trading platform.